I am a clinical fellow in the Division of Oncology, with a focus on adolescent/young adult oncology and solid tumors. I received my Honors BSc in Life Sciences from Queen's University in Kingston, Ontario; my MSc in Immunology from the University of Oxford; and my MD from Dalhousie University in Halifax, Nova Scotia. I spent the next nine years at the University of British Columbia in Vancouver, Canada. After three years of general surgery training, I transferred into and completed my pediatrics residency and a subsequent fellowship in pediatric hematology/oncology. My clinical and research interests include adolescent/young adult oncology, solid tumors, early phase trials and medical humanities/patient narratives.
I was drawn to this specialty by the bravery, strength and resilience of pediatric cancer patients and their families. I value a patient and family-centered approach and strive to provide excellent clinical care.
Medical School: Dalhousie University, Halifax, Nova Scotia, Canada, 2013.
Graduate School: MSc, Immunology, University of Oxford, Oxfordshire, UK, 2008.
Residency: General Surgery, University of British Columbia, Vancouver, British Columbia, Canada, 2013 - 2016.
Residency: Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada, 2016 - 2019.
Fellowship: Pediatric Hematology / Oncology, University of British Columbia, Vancouver, British Columbia, Canada, 2019 - 2022.
Certification: FRCPC, Pediatrics, Royal College of Physicians and Surgeons of Canada, 2019.
Certification: FRCPC, Pediatric Hematology / Oncology, Royal College of Physicians and Surgeons of Canada, 2022.
Adolescent / young adult oncology; solid tumors
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Research-Based Theater in the Pediatric Oncology Setting: Balancing Ethical Tensions. Qualitative Inquiry. 2023; 29:305-313.
Primary cutaneous follicle center lymphoma of the medial canthus of the eye in an 11-year old. Pediatric Blood and Cancer. 2022; 69:e29630.
Commentary on McNeil et al. and Wolfe et al. 2022; 6:1.
Precocious puberty: a red flag for malignancy in childhood. British Columbia Medical Journal. 2021; 63:242-246.